Anacor Pharmaceuticals, Inc. Insider Trading for September 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anacor Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Anacor Pharmaceuticals, Inc. for September 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30 2014 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 25.00 | 20,000 | 500,000 | 2,725,535 | 2.7 M to 2.7 M (-0.73 %) |
| Sep 22 2014 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 24.87 | 738,500 | 18,366,495 | 2,745,535 | 3.5 M to 2.7 M (-21.20 %) |
| Sep 22 2014 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 24.87 | 1,500 | 37,305 | 3,484,035 | 3.5 M to 3.5 M (-0.04 %) |
| Sep 16 2014 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 24.99 | 75,000 | 1,874,250 | 3,485,535 | 3.6 M to 3.5 M (-2.11 %) |
| Sep 16 2014 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 24.98 | 15,000 | 374,700 | 3,560,535 | 3.6 M to 3.6 M (-0.42 %) |
| Sep 12 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | M | 5.00 | 4,953 | 24,765 | 0 | |
| Sep 12 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | M | 7.25 | 5,047 | 36,591 | 9,952 | |
| Sep 12 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Sell | S | 24.25 | 4,953 | 120,110 | 3,995 | 8.9 K to 4 K (-55.35 %) |
| Sep 12 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Buy | M | 5.00 | 4,953 | 24,765 | 8,948 | 4 K to 8.9 K (+123.98 %) |
| Sep 12 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Sell | S | 24.25 | 5,047 | 122,390 | 3,995 | 9 K to 4 K (-55.82 %) |
| Sep 12 2014 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Buy | M | 7.25 | 5,047 | 36,591 | 9,042 | 4 K to 9 K (+126.33 %) |
| Sep 12 2014 | ANAC | Anacor Pharmaceuti ... | WIERENGA WENDALL | Director | Option Exercise | A | 25.48 | 27,000 | 687,960 | 27,000 | |
| Sep 08 2014 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Executive Vice Pres ... | Buy | P | 22.05 | 1,229 | 27,095 | 170,000 | 168.8 K to 170 K (+0.73 %) |
| Sep 08 2014 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Executive Vice Pres ... | Buy | P | 21.77 | 5,361 | 116,712 | 168,771 | 163.4 K to 168.8 K (+3.28 %) |
| Sep 04 2014 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Option Exercise | M | 7.25 | 22,325 | 161,856 | 8,654 | |
| Sep 04 2014 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Option Exercise | M | 5.00 | 9,860 | 49,300 | 0 | |
| Sep 04 2014 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 23.32 | 600 | 13,989 | 6,600 | 7.2 K to 6.6 K (-8.33 %) |
| Sep 04 2014 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 23.34 | 94 | 2,194 | 7,200 | 7.3 K to 7.2 K (-1.29 %) |
| Sep 04 2014 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 23.34 | 1,000 | 23,335 | 7,294 | 8.3 K to 7.3 K (-12.06 %) |
| Sep 04 2014 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 23.30 | 22,325 | 520,108 | 8,294 | 30.6 K to 8.3 K (-72.91 %) |
| Sep 04 2014 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Buy | M | 7.25 | 22,325 | 161,856 | 30,619 | 8.3 K to 30.6 K (+269.17 %) |
| Sep 04 2014 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 23.30 | 9,860 | 229,709 | 8,294 | 18.2 K to 8.3 K (-54.31 %) |
| Sep 04 2014 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Buy | M | 5.00 | 9,860 | 49,300 | 18,154 | 8.3 K to 18.2 K (+118.88 %) |
| Sep 04 2014 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Sell | S | 23.34 | 6,875 | 160,444 | 85,850 | 92.7 K to 85.9 K (-7.41 %) |